Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Telomere length regulation protein TEL2 homolog (TELO2) is a conserved protein that acts as a key molecular adaptor and regulator of the DNA damage response. It is part of the TTT complex (TELO2-TTI1-TTI2), crucial for the stability and function of the phosphatidylinositol 3-kinase-related protein kinases (PIKKs), which include ATM, ATR, and mTOR. These kinases govern diverse cellular responses, including cell growth, survival, and genome maintenance. While initially characterized for a role in telomere length regulation in yeast, mammalian TELO2 is primarily known for stabilizing PIKK proteins, facilitating the assembly and activity of the mTOR complexes, and contributing to resistance against DNA damage stresses such as ionizing radiation and chemotherapeutic agents. Mutations in TELO2 are associated with syndromes featuring developmental delay, cerebellar atrophy, and seizures. Though critical in oncology-relevant pathways, TELO2 is not currently a direct drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Telomere length regulation protein TEL2 homolog (TELO2).